| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $660.6M | +11.6% |
| Cost of Revenue | $370.5M | +6.8% |
| Gross Profit | $290.1M | +18.6% |
| R&D Expense | $31.2M | +14.1% |
| SG&A Expense | $259.7M | +6.8% |
| Operating Income | -$92.1M | +14.5% |
| Pre-tax Income | -$80.7M | +16.9% |
| Income Tax | -$1.9M | +78.7% |
| Net Income | -$78.7M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $367.0M | +7.2% |
| Accounts Receivable | $150.5M | +14.7% |
| Inventory | $26.7M | +10.7% |
| Current Assets | $596.0M | -0.1% |
| Total Assets | $1.64B | -2.6% |
| Current Liabilities | $301.2M | +212.8% |
| Long-term Debt | $541.1M | +0.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $7.0M | +459.6% |
| Capital Expenditures | $41.1M | +42.8% |
| Investing Cash Flow | $12.9M | -83.2% |
| Financing Cash Flow | $4.6M | +2.0% |
| Free Cash Flow | -$34.0M | -10.9% |
| +10.5% |
| Total Liabilities |
| $735.7M |
| -0.5% |
| Stockholders' Equity | $902.3M | -4.2% |